Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Paper
Temozolomide plus rituximab in the treatment of recurrent central nervous system lymphoma:Case report and literature review
( views:358, downloads:36 )
Author:
No author available
Journal Title:
CHINESE-GERMAN JOURNAL OF CLINICAL ONCOLOGY
Issue:
12
DOI:
10.1007/s10330-009-0127-2
Key Word:
recurrent;primary central nervous system lymphoma;temozolomide;rituximab;treatment
Abstract: No abstract available
Reference
[1]Ferreri AJ,Villa E,Reni M.
Second-line treatment for primary central nervous system lymphoma.
[J].1999,79(3).
[2]Demopoulos A,DeAngelis LM,Enting RH,etc.
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
[J].2004,63(5).
[3]Eghbali H,Le-Mevel A,Blay JY,etc.
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
[J].1998,16(3).
[4]Nelson DF.
Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).
[J].1999,43(3).
[5]Abrey LE,Hochman J,Zucca E,etc.
Summary statement on primary central nervous system lymphomas from the eighth international conference on malignant lymphoma, lugano, Switzerland, june 12 to 15, 2002.
[J].2003,21(12).
[6]M, Reni,A J, Ferreri.
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
[J].2001,80 Suppl 3.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn